GS
IDNA icon

GTS Securities’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

GTS Securities’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$677K Buy
+23,301
New +$676K 0.02% 564
2024
Q3 		– Sell
-10,027
Closed -$232K – 4239
2024
Q2 		$232K Buy
+10,027
New +$235K ﹤0.01% 3323

Other funds holding IDNA

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

GTS Securities's IDNA Position: Q1 2026 in Review

GTS Securities opened a new position in iShares Genomics Immunology and Healthcare ETF (IDNA) in Q1 2026: 23,301 shares worth $677K. The stake represents 0.02% of the portfolio and ranks #564 among its holdings. This is a return to the name: GTS Securities previously reported a position in IDNA as recently as Q2 2024.

GTS Securities first reported a position in IDNA in Q2 2024 and has held it in 2 quarters since. 60 funds tracked by Wall St. Rank hold IDNA as of Q1 2026.

  • GTS Securities held 23,301 shares of iShares Genomics Immunology and Healthcare ETF worth $677K as of Q1 2026.
  • iShares Genomics Immunology and Healthcare ETF was a new GTS Securities position in Q1 2026.
  • iShares Genomics Immunology and Healthcare ETF made up 0.02% of GTS Securities's portfolio in Q1 2026, its #564 holding.
  • GTS Securities first reported a position in iShares Genomics Immunology and Healthcare ETF in Q2 2024 and has held it in 2 quarters since.
  • 60 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.